NEW YORK (360Dx) – Israeli in vitro diagnostics firm Todos Medical today announced a distribution deal with Orot+ for Todos' TM-B2 blood tests for breast cancer screening in Romania and Austria.
Orto+, headquartered in Tel Aviv, Israel will be responsible for the costs of marketing and distributing TM-B2. Todos will use data from the commercialization efforts to support further development and commercialization of the test in other geographies, it said. Additional terms of the agreement were not disclosed.